Abstract
Starting from birth, sex hormonal fluctuations mark the various phases of female life leading from puberty to menopause.
During the aging process, there are physiological, structural, and functional changes of the hypothalamus-hypophysis-gonadal axis that lead over time to reach the definitive menopausal state. At the central level (thalamus, hypothalamus, amygdala, medial prefrontal cortex, and cingulate gyrus), changes in hormone secretion and receptor reassignment determine, in part of the perimenopausal population, neurological symptoms such as mood and sleep disorders, Alzheimer disease, hot flushes, and migraine. The mainly implicated receptors have been identified in ER α and ER β; thanks to the link with sex hormones they lead to the activation of different pathways of response. Moreover, they allow the nervous system to modulate synapsis, neuronal plasticity, cell-cell communication, myelin organization and stability; they protect from oxygen deprivation, stroke, and Aβ- and glutamate-induced toxicities. A further proof could be what happens when women undergo surgical menopause (bilateral oophorectomy) before their natural aging process: neurological symptoms seem to have a sudden and severe onset. Nowadays numerous studies are emerging, able to precisely define the intrinsic causes of these changes, in a way to improve in the near future the postmenopausal quality of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vega JN, Zurkovsky L, Albert K, Melo A, Boyd B, Dumas J, et al. Altered brain connectivity in early postmenopausal women with subjective cognitive impairment. Front Neurosci. 2016;10:433.
Foster TC. Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus. 2012;22:656–69.
Daniel JM, Witty CF, Rodgers SP. Long-term consequences of estrogens administered in midlife on female cognitive aging. Horm Behav. 2015;74:77–85.
Hara Y, Waters EM, McEwen BS, Morrison JH. Estrogen effects on cognitive and synaptic health over the life course. Physiol Rev. 2015;95(3):785–807.
Gonzalez M, Cabrera-Socorro A, Perez-Garcia CG, Fraser JD, Lopez FJ, Alonso R, et al. Distribution patterns of estrogen receptor alpha and beta in the human cortex and hippocampus during development and adulthood. J Comp Neurol. 2007;503:790–802.
Bomberg J, Schott LL, Kraviz H, Sowers MF, Avis NE, Gold EB, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition results from the study of women’s health across the nation (SWAN). Arch Gen Psychiatry. 2010;67(6):598–607.
Giannini A, Gennazzani AR, Simoncini T. Management of symptoms during the menopausal transition. In: Frontiers in gynecological endocrinology. Ovarian function and reproduction—from needs to possibilities. ISGE Series. Vol 3(19). New York: Springer; 2014. p. 161–7.
Farrag AF, Khedr EM, Abdel-Aleem H, Rageh TA. Effects of surgical menopause on cognitive functions. Dement Geritar Cogn Disord. 2002;13:193–8.
Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007;92(8):3040–3.
Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Ann Epidemiol. 1994;4(3):214–20.
Hui L, Wang Y, Zhou F, Ma X, Yan R, Zhang L, et al. Association between MKP-1, BDNF, and gonadal hormones with depression on perimenopausal women. J Womens Health (Larchmt). 2016;25(1):71–7.
Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis. 2000;31(Suppl 5):S157–61.
Kenna H, et al. Fasting plasma insulin and the default mode network in women at risk for Alzheimer’s disease. Neurobiol Aging. 2013;34:641–9.
Short RA, Bowen RL, O’Brien PC, Graff-Radford NR. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76(9):906–9.
Long J, He P, Shen Y, Li R. New evidence of mitochondria dysfunction in the female Alzheimer’s disease brain: deficiency of estrogen receptor-beta. J Alzheimers Dis. 2012;30:545–58.
Brinton RD. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57–74.
Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology-a bidirectional relationship. Nat Rev Neurol. 2014;10:115–9.
Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11:393–405.
Sowers MF, Zheng H, Kravitz HM, et al. Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Sleep Quality Index. Sleep. 2008;31(10):1339–49.
Avis NE, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women’s Health Across the Nation. Menopause. 2009;16:860–9.
Freedman RR, Benton MD, Genik RJ, Graydon FX. Cortical activation during menopausal hot flashes. Fertil Steril. 2006;85:674–8.
Thurston RC, Chang Y, Mancuso P, Matthews KA. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women’s Health Across the Nation. Fertil Steril. 2013;100:793–800.
Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause—global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215.
Hagemann G, Ugur T, Schleussner E, Mentzel HJ, Fitzek C, Witte OW, Gaser C. Changes in brain size during the menstrual cycle. PLoS One. 2011;6(2):e14655.
Goto M, Abe O, Miyati T, Inano S, Hayashi N, Aoki S, et al. 3 Tesla MRI detects accelerated hippocampal volume reduction in postmenopausal women. J Magn Reson Imaging. 2011;33(1):48–53.
Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Lowe VJ, Fields JA, et al. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology. 2018;90(16):e1404–12.
Tschanz JT, Norton MC, Zandi PP, Lyketsos CG. The cache county study on memory in aging: factors affecting risk of Alzheimer’s disease and its progression after onset. Int Rev Psychiatry. 2013;25(6):673–85.
Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS cognitive and affective study. PLoS Med. 2015;12(6):e1001833.
Brinton RD, Nilsen J. Effects of estrogen plus progestin on risk of dementia. J Am Med Assoc. 2003;290:1706.
Berent-Spillson A, Briceno E, Pinsky A, Simmen A, Persad CC, Zubieta J, et al. Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology. 2015;59:25–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Antonelli, A., Giannini, A., Caretto, M., Simoncini, T., Genazzani, A.R. (2019). Impact of Menopause on Brain Functions. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-13936-0_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13935-3
Online ISBN: 978-3-030-13936-0
eBook Packages: MedicineMedicine (R0)